Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Immunity
|
February 22, 2011
Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formation
Shelly M Wuerzberger-Davis, Yuhong Chen, David T Yang, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
July 24, 2013
Disaster planning: the basics of creating a burn mass casualty disaster plan for a burn center
Randy D Kearns, Kathe M Conlon, Andrea L Valenta, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
August 29, 2014
Advanced Burn Life Support for Day-to-Day Burn Injury Management and Disaster Preparedness: Stakeholder Experiences and Student Perceptions Following 56 Advanced Burn Life Support Courses
Randy D Kearns, Shiara M Ortiz-Pujols, Christopher K Craig, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 11, 2022
Current practices for QSP model assessment: an IQ consortium survey
Jason R Chan, Richard Allen, Britton Boras, et al.
Cell Reports. Medicine
|
November 12, 2025
A combined genomic arrhythmia propensity score delineates cumulative risk
Tanner O Monroe, Megan J Puckelwartz, Lorenzo L Pesce, et al.
JAMA Cardiology
|
August 11, 2021
Genomic Autopsy of Sudden Deaths in Young Individuals
Gregory Webster, Megan J Puckelwartz, Lorenzo L Pesce, et al.
Journal of the American Heart Association
|
March 25, 2021
Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
Megan J Puckelwartz, Lorenzo L Pesce, Lisa M Dellefave-Castillo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 23, 2019
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM
Jessica B Casaletto, Melissa L Geddie, Adnan O Abu-Yousif, et al.
Science Translational Medicine
|
February 1, 2023
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events
Anette C Karle, Matthias B Wrobel, Stephan Koepke, et al.
Science Translational Medicine
|
February 1, 2023
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Immunity
|
February 22, 2011
Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formation
Shelly M Wuerzberger-Davis, Yuhong Chen, David T Yang, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
July 24, 2013
Disaster planning: the basics of creating a burn mass casualty disaster plan for a burn center
Randy D Kearns, Kathe M Conlon, Andrea L Valenta, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
August 29, 2014
Advanced Burn Life Support for Day-to-Day Burn Injury Management and Disaster Preparedness: Stakeholder Experiences and Student Perceptions Following 56 Advanced Burn Life Support Courses
Randy D Kearns, Shiara M Ortiz-Pujols, Christopher K Craig, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 11, 2022
Current practices for QSP model assessment: an IQ consortium survey
Jason R Chan, Richard Allen, Britton Boras, et al.
Cell Reports. Medicine
|
November 12, 2025
A combined genomic arrhythmia propensity score delineates cumulative risk
Tanner O Monroe, Megan J Puckelwartz, Lorenzo L Pesce, et al.
JAMA Cardiology
|
August 11, 2021
Genomic Autopsy of Sudden Deaths in Young Individuals
Gregory Webster, Megan J Puckelwartz, Lorenzo L Pesce, et al.
Journal of the American Heart Association
|
March 25, 2021
Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
Megan J Puckelwartz, Lorenzo L Pesce, Lisa M Dellefave-Castillo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 23, 2019
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM
Jessica B Casaletto, Melissa L Geddie, Adnan O Abu-Yousif, et al.
Science Translational Medicine
|
February 1, 2023
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events
Anette C Karle, Matthias B Wrobel, Stephan Koepke, et al.
Science Translational Medicine
|
February 1, 2023
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, et al.
Page
of 12